Drug recall · April 29, 2026
Claravis recall
Why: Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with 10x10 blister packs NDC 0555-1054-60; b) 30-count carton, NDC 0555-1054-86, with 3X10 blister pack NDC 0555-1054-60; Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.
- Lots / codes
Lots#: 100067507, 100067508, Exp 07/31/2026
- Quantity
- 5,101 cartons
- Company
- Teva Pharmaceuticals USA, Inc, Parsippany, NJ
- Distribution
- Nationwide in the USA, Puerto Rico and Virgin Islands
- Initiated
- April 6, 2026 · Voluntary: Firm initiated
- Classified
- May 6, 2026
- Reported
- April 29, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Claravis
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.